arrow
O

Olga Martínez-Sáez

Johns Hopkins University
H指数:20
被引数:2,745

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer

免疫和增殖基因特征及基质肿瘤浸润淋巴细胞与I期三阴性乳腺癌患者临床结局的关联

2026-09-040
PRE
Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer

雌激素受体阳性、HER2阴性乳腺癌年轻女性的基因组与临床特征

2025-09-240
PREAI
Preoperative Radiotherapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results from the YOUNGSTER Trial

术前放疗诱导的分子和免疫调控在早期乳腺癌中的作用:YOUNGSTER试验的结果

2025-08-050
OA
Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review

紫杉醇相关性Kounis综合征I型:1例年轻HER2阳性乳腺癌患者报告及基因组学在阐明复杂治疗情境中作用:病例报告及综述

BREAST
IF7.9
2025-06-010
OAAI
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab

HER2DX ERBB2 mRNA评分:用于接受化疗、曲妥珠单抗和帕妥珠单抗治疗的一线晚期HER2阳性乳腺癌

2025-04-250
OA
Correlation of the HER2DX Genomic Test withPathologic Features in Early-Stage HER2+BreastCancer
2025-03-010
PRE
Impact of B cell and plasma cell infiltration on survival in early-stage breast cancer (BC) without recurrence

B细胞和浆细胞浸润对无复发生存期的早期乳腺癌(BC)的影响

2024-09-010
PRE
Toxicities in breast cancer patients undergoing neoadjuvant immune checkpoint inhibitor therapy: Insights from a nurse practitioner perspective

乳腺癌患者在接受新辅助免疫检查点抑制剂治疗时的毒副反应:从执业护士角度的见解

2024-09-010
PRE
Clinical and molecular characteristics of early-stage triple-negative breast cancer (eTNBC) patients with germline pathogenic variants in homologous recombination repair genes

携带同源重组修复基因胚系致病性变异的早期三阴性乳腺癌(eTNBC)患者的临床与分子特征

2024-09-010
PRE
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
2024-07-111
OAAI
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
2024-07-112
OAAI
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies

早期三阴性乳腺癌 (TNBC) 的14基因b细胞免疫特征: 七项研究的汇总分析

2024-04-013
OAAI
Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network d Breast dataset (SCAN-B)
2024-03-018
OAAI